| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |